| Year |
Citation |
Score |
| 2020 |
Canu V, Donzelli S, Sacconi A, Lo Sardo F, Pulito C, Bossel N, Di Benedetto A, Muti P, Botti C, Domany E, Bicciato S, Strano S, Yarden Y, Blandino G. Aberrant transcriptional and post-transcriptional regulation of SPAG5, a YAP-TAZ-TEAD downstream effector, fuels breast cancer cell proliferation. Cell Death and Differentiation. PMID 33230261 DOI: 10.1038/s41418-020-00677-9 |
0.3 |
|
| 2019 |
Mastroianni A, Ciniselli CM, Panella R, Macciotta A, Cavalleri A, Venturelli E, Taverna F, Mazzocchi A, Bruno E, Muti P, Berrino F, Verderio P, Morelli D, Pasanisi P. Monitoring Vitamin B in Women Treated with Metformin for Primary Prevention of Breast Cancer and Age-Related Chronic Diseases. Nutrients. 11. PMID 31067706 DOI: 10.3390/Nu11051020 |
0.327 |
|
| 2018 |
Tang GH, Satkunam M, Pond GR, Steinberg GR, Blandino G, Schünemann HJ, Muti P. Association of metformin with breast cancer incidence and mortality in patients with type 2 diabetes: a GRADE assessed systematic review and meta-analysis. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29618465 DOI: 10.1158/1055-9965.Epi-17-0936 |
0.396 |
|
| 2018 |
Broadfield LA, Saigal A, Foley K, Szamosi JC, Blandino G, Tsakiridis T, Muti P, Schertzer J, Steinberg GR. Mechanisms of Metformin on Colon Cancer Inhibition: Roles of the Gut Microbiome, Butyrate and AMPK Canadian Journal of Diabetes. 42. DOI: 10.1016/J.Jcjd.2018.08.006 |
0.317 |
|
| 2017 |
Muti P, Donzelli S, Sacconi A, Hossain A, Ganci F, Frixa T, Sieri S, Krogh V, Berrino F, Biagioni F, Strano S, Beyene J, Yarden Y, Blandino G. MiRNA-513a-5p Inhibits Progesterone Receptor Expression and Constitutes a Risk Factor For Breast Cancer: The ORDET Prospective Study. Carcinogenesis. PMID 29126102 DOI: 10.1093/Carcin/Bgx126 |
0.379 |
|
| 2017 |
Secreto G, Muti P, Sant M, Meneghini E, Krogh V. Medical ovariectomy in menopausal breast cancer patients with high testosterone levels. Endocrine-Related Cancer. PMID 28814452 DOI: 10.1530/Erc-17-0251 |
0.395 |
|
| 2017 |
Pulito C, Mori F, Sacconi A, Goeman F, Ferraiuolo M, Pasanisi P, Campagnoli C, Berrino F, Fanciulli M, Ford RJ, Levrero M, Pediconi N, Ciuffreda L, Milella M, Steinberg GR, ... ... Muti P, et al. Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities. Cell Discovery. 3: 17022. PMID 28698800 DOI: 10.1038/Celldisc.2017.22 |
0.325 |
|
| 2017 |
Muti P, Secreto G, Krogh V. Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer. Breast Cancer Research and Treatment. PMID 28315966 DOI: 10.1007/S10549-017-4194-8 |
0.414 |
|
| 2016 |
Secreto G, Sieri S, Agnoli C, Grioni S, Muti P, Zumoff B, Sant M, Meneghini E, Krogh V. A novel approach to breast cancer prevention: reducing excessive ovarian androgen production in elderly women. Breast Cancer Research and Treatment. PMID 27393623 DOI: 10.1007/S10549-016-3901-1 |
0.46 |
|
| 2016 |
Donzelli S, Blandino G, Muti P. Use of Buffy Coat miRNA Profiling for Breast Cancer Prediction in Healthy Women. Methods in Molecular Biology (Clifton, N.J.). 1379: 13-9. PMID 26608286 DOI: 10.1007/978-1-4939-3191-0_2 |
0.43 |
|
| 2016 |
Marcinko K, Villani L, Houde V, Muti P, Steinberg G, Tsakiridis T. 90: Combined Salicylate (SAL) - Metformin (MET) Treatment Induces Increased Tumour Suppression and Radiosensitization in Preclinical Models of Prostate Cancer (PRCA) Radiotherapy and Oncology. 120. DOI: 10.1016/S0167-8140(16)33489-2 |
0.304 |
|
| 2015 |
Donzelli S, Mori F, Bellissimo T, Sacconi A, Casini B, Frixa T, Roscilli G, Aurisicchio L, Facciolo F, Pompili A, Carosi MA, Pescarmona E, Segatto O, Pond G, Muti P, et al. Epigenetic silencing of miR-145-5p contributes to brain metastasis. Oncotarget. 6: 35183-201. PMID 26440147 DOI: 10.18632/Oncotarget.5930 |
0.314 |
|
| 2015 |
Cancarini I, Krogh V, Agnoli C, Grioni S, Matullo G, Pala V, Pedraglio S, Contiero P, Riva C, Muti P, Sieri S. Micronutrients Involved in One-Carbon Metabolism and Risk of Breast Cancer Subtypes. Plos One. 10: e0138318. PMID 26376452 DOI: 10.1371/Journal.Pone.0138318 |
0.4 |
|
| 2015 |
O'Brien AJ, Villani LA, Broadfield LA, Houde VP, Galic S, Blandino G, Kemp BE, Tsakaridis T, Muti P, Steinberg GR. Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis. The Biochemical Journal. PMID 25940306 DOI: 10.1042/Bj20150122 |
0.314 |
|
| 2015 |
Pulito C, Terrenato I, Di Benedetto A, Korita E, Goeman F, Sacconi A, Biagioni F, Blandino G, Strano S, Muti P, Mottolese M, Falvo E. Cdx2 polymorphism affects the activities of vitamin D receptor in human breast cancer cell lines and human breast carcinomas. Plos One. 10: e0124894. PMID 25849303 DOI: 10.1371/Journal.Pone.0124894 |
0.398 |
|
| 2015 |
Key TJ, Appleby PN, Reeves GK, Travis RC, Brinton LA, Helzlsouer KJ, Dorgan JF, Gapstur SM, Gaudet MM, Kaaks R, Riboli E, Rinaldi S, Manjer J, Hallmans G, Giles GG, ... ... Muti P, et al. Steroid hormone measurements from different types of assays in relation to body mass index and breast cancer risk in postmenopausal women: Reanalysis of eighteen prospective studies. Steroids. 99: 49-55. PMID 25304359 DOI: 10.1016/J.Steroids.2014.09.001 |
0.696 |
|
| 2014 |
Pulito C, Donzelli S, Muti P, Puzzo L, Strano S, Blandino G. microRNAs and cancer metabolism reprogramming: the paradigm of metformin. Annals of Translational Medicine. 2: 58. PMID 25333033 DOI: 10.3978/J.Issn.2305-5839.2014.06.03 |
0.337 |
|
| 2014 |
Muti P, Sacconi A, Hossain A, Donzelli S, Ben Moshe NB, Ganci F, Sieri S, Krogh V, Berrino F, Biagioni F, Strano S, Beyene J, Yarden Y, Blandino G. Downregulation of microRNAs 145-3p and 145-5p is a long-term predictor of postmenopausal breast cancer risk: The ORDET prospective study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 2471-81. PMID 25073626 DOI: 10.1158/1055-9965.Epi-14-0398 |
0.402 |
|
| 2014 |
Akl EA, Kahale L, Barba M, Neumann I, Labedi N, Terrenato I, Sperati F, Muti P, Schünemann H. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer. The Cochrane Database of Systematic Reviews. 7: CD006650. PMID 25004410 DOI: 10.1002/14651858.Cd006650.Pub4 |
0.336 |
|
| 2014 |
Cioce M, Valerio M, Casadei L, Pulito C, Sacconi A, Mori F, Biagioni F, Manetti C, Muti P, Strano S, Blandino G. Metformin-induced metabolic reprogramming of chemoresistant ALDHbright breast cancer cells. Oncotarget. 5: 4129-43. PMID 24980829 DOI: 10.18632/Oncotarget.1864 |
0.326 |
|
| 2014 |
Akl EA, Kahale L, Neumann I, Barba M, Sperati F, Terrenato I, Muti P, Schünemann H. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. The Cochrane Database of Systematic Reviews. 6: CD006649. PMID 24945634 DOI: 10.1002/14651858.Cd006649.Pub6 |
0.333 |
|
| 2014 |
Muti P. Is progesterone a neutral or protective factor for breast cancer? Nature Reviews. Cancer. 14: 146. PMID 24442141 DOI: 10.1038/Nrc3518-C1 |
0.413 |
|
| 2014 |
Majercak K, Nghiem E, Byrne C, Muti P, Barba M, Lavigne J, Faupel-Badger J, Teter B, Fuhrman B. Mammographic Density in Association with Smoking Status and Smoking Histories in a Sample of Postmenopausal Women: Results From a Cross-Sectional Study Value in Health. 17: A72. DOI: 10.1016/J.Jval.2014.03.421 |
0.745 |
|
| 2013 |
Pulito C, Sanli T, Rana P, Muti P, Blandino G, Strano S. Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention. Metabolites. 3: 1051-75. PMID 24958265 DOI: 10.3390/Metabo3041051 |
0.334 |
|
| 2013 |
Key TJ, Appleby PN, Reeves GK, Travis RC, Alberg AJ, Barricarte A, Berrino F, Krogh V, Sieri S, Brinton LA, Dorgan JF, Dossus L, Dowsett M, Eliassen AH, ... ... Muti P, et al. Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. The Lancet. Oncology. 14: 1009-19. PMID 23890780 DOI: 10.1016/S1470-2045(13)70301-2 |
0.474 |
|
| 2013 |
Schernhammer ES, Sperati F, Razavi P, Agnoli C, Sieri S, Berrino F, Krogh V, Abbagnato C, Grioni S, Blandino G, Schunemann HJ, Muti P. Endogenous sex steroids in premenopausal women and risk of breast cancer: the ORDET cohort. Breast Cancer Research : Bcr. 15: R46. PMID 23777922 DOI: 10.1186/Bcr3438 |
0.475 |
|
| 2013 |
Contiero P, Berrino F, Tagliabue G, Mastroianni A, Di Mauro MG, Fabiano S, Annulli M, Muti P. Fasting blood glucose and long-term prognosis of non-metastatic breast cancer: a cohort study. Breast Cancer Research and Treatment. 138: 951-9. PMID 23568483 DOI: 10.1007/S10549-013-2519-9 |
0.358 |
|
| 2013 |
Muti P, Rana P. Can daily multivitamin prevent cancer? Results from the Physicians' Health Study. Polskie Archiwum Medycyny WewnęTrznej. 123: 83-4. PMID 23535857 DOI: 10.20452/Pamw.1615 |
0.315 |
|
| 2013 |
Clendenen TV, Arslan AA, Lokshin AE, Liu M, Lundin E, Koenig KL, Berrino F, Hallmans G, Idahl A, Krogh V, Lukanova A, Marrangoni A, Muti P, Nolen BM, Ohlson N, et al. Circulating prolactin levels and risk of epithelial ovarian cancer. Cancer Causes & Control : Ccc. 24: 741-8. PMID 23378139 DOI: 10.1007/S10552-013-0156-6 |
0.429 |
|
| 2013 |
Dallal CM, Stone RA, Cauley JA, Ness RB, Vogel VG, Fentiman IS, Fowke JH, Krogh V, Loft S, Meilahn EN, Muti P, Olsen A, Overvad K, Sieri S, Tjønneland A, et al. Urinary estrogen metabolites and breast cancer: a combined analysis of individual level data. The International Journal of Biological Markers. 28: 3-16. PMID 22865302 DOI: 10.5301/Jbm.2012.9353 |
0.436 |
|
| 2012 |
Biagioni F, Bossel Ben-Moshe N, Fontemaggi G, Canu V, Mori F, Antoniani B, Di Benedetto A, Santoro R, Germoni S, De Angelis F, Cambria A, Avraham R, Grasso G, Strano S, Muti P, et al. miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours. Embo Molecular Medicine. 4: 1214-29. PMID 23125021 DOI: 10.1002/Emmm.201201483 |
0.389 |
|
| 2012 |
Fuhrman BJ, Brinton LA, Pfeiffer RM, Xu X, Veenstra TD, Teter BE, Byrne C, Dallal CM, Barba M, Muti PC, Gierach GL. Estrogen metabolism and mammographic density in postmenopausal women: a cross-sectional study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1582-91. PMID 22736791 DOI: 10.1158/1055-9965.Epi-12-0247 |
0.796 |
|
| 2012 |
Lundin E, Wirgin I, Lukanova A, Afanasyeva Y, Krogh V, Axelsson T, Hemminki K, Clendenen TV, Arslan AA, Ohlson N, Sieri S, Roy N, Koenig KL, Idahl A, Berrino F, ... ... Muti P, et al. Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer. Cancer Epidemiology. 36: 445-52. PMID 22633539 DOI: 10.1016/J.Canep.2012.04.006 |
0.376 |
|
| 2012 |
Benassi B, Flavin R, Marchionni L, Zanata S, Pan Y, Chowdhury D, Marani M, Strano S, Muti P, Blandino G, Loda M. MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer. Cancer Discovery. 2: 236-47. PMID 22585994 DOI: 10.1158/2159-8290.Cd-11-0219 |
0.326 |
|
| 2012 |
Falvo E, Strigari L, Citro G, Giordano C, Boboc G, Fabretti F, Bruzzaniti V, Bellesi L, Muti P, Blandino G, Pinnarò P. SNPs in DNA repair or oxidative stress genes and late subcutaneous fibrosis in patients following single shot partial breast irradiation. Journal of Experimental & Clinical Cancer Research : Cr. 31: 7. PMID 22272830 DOI: 10.1186/1756-9966-31-7 |
0.3 |
|
| 2012 |
Sieri S, Muti P, Claudia A, Berrino F, Pala V, Grioni S, Abagnato CA, Blandino G, Contiero P, Schunemann HJ, Krogh V. Prospective study on the role of glucose metabolism in breast cancer occurrence. International Journal of Cancer. 130: 921-9. PMID 21413010 DOI: 10.1002/Ijc.26071 |
0.392 |
|
| 2012 |
Pulito C, Terrenato I, Sacconi A, Biagioni F, Mottolese M, Blandino G, Muti P, Falvo E, Strano S. P1.20 CDX2 VDR Polymorphism Impinges on the Response of Cultured Breast Cancer Cell Lines to Vitamin D Annals of Oncology. 23. DOI: 10.1016/S0923-7534(20)31311-9 |
0.41 |
|
| 2011 |
Zeleniuch-Jacquotte A, Shore RE, Afanasyeva Y, Lukanova A, Sieri S, Koenig KL, Idahl A, Krogh V, Liu M, Ohlson N, Muti P, Arslan AA, Lenner P, Berrino F, Hallmans G, et al. Postmenopausal circulating levels of 2-and 16α-hydroxyestrone and risk of endometrial cancer British Journal of Cancer. 105: 1458-1464. PMID 21952628 DOI: 10.1038/Bjc.2011.381 |
0.385 |
|
| 2011 |
Falvo E, Strigari L, Citro G, Giordano C, Arcangeli S, Soriani A, D'Alessio D, Muti P, Blandino G, Sperduti I, Pinnarò P. Dose and polymorphic genes xrcc1, xrcc3, gst play a role in the risk of articledeveloping erythema in breast cancer patients following single shot partial breast irradiation after conservative surgery. Bmc Cancer. 11: 291. PMID 21749698 DOI: 10.1186/1471-2407-11-291 |
0.38 |
|
| 2011 |
Muti P, Benassi B, Falvo E, Santoro R, Galanti S, Citro G, Carrubba G, Blandino G, Strano S. Omics underpins novel clues on VDR chemoprevention target in breast cancer. Omics : a Journal of Integrative Biology. 15: 337-46. PMID 21348760 DOI: 10.1089/Omi.2010.0086 |
0.41 |
|
| 2011 |
Fuhrman BJ, Brinton LA, Pfeiffer RM, Teter BE, Dallal C, Byrne C, Muti PC, Gierach GL. Abstract A8: Estrogen metabolism and mammographic density in postmenopausal women Cancer Prevention Research. 4. DOI: 10.1158/1940-6207.Prev-11-A8 |
0.794 |
|
| 2010 |
Cuppone F, Bria E, Giannarelli D, Vaccaro V, Milella M, Nisticò C, Ruggeri EM, Sperduti I, Bracarda S, Pinnarò P, Lanzetta G, Muti P, Cognetti F, Carlini P. Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: meta-analysis of randomized trials. Bmc Cancer. 10: 675. PMID 21143897 DOI: 10.1186/1471-2407-10-675 |
0.318 |
|
| 2010 |
Cioce M, Gherardi S, Viglietto G, Strano S, Blandino G, Muti P, Ciliberto G. Mammosphere-forming cells from breast cancer cell lines as a tool for the identification of CSC-like- and early progenitor-targeting drugs. Cell Cycle (Georgetown, Tex.). 9: 2878-87. PMID 20581442 DOI: 10.4161/Cc.9.14.12371 |
0.357 |
|
| 2010 |
Schernhammer ES, Berrino F, Krogh V, Secreto G, Micheli A, Venturelli E, Grioni S, Sempos CT, Cavalleri A, Schünemann HJ, Strano S, Muti P. Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 729-37. PMID 20200429 DOI: 10.1158/1055-9965.Epi-09-1229 |
0.453 |
|
| 2010 |
Agnoli C, Berrino F, Abagnato CA, Muti P, Panico S, Crosignani P, Krogh V. Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: A nested case-control study Nutrition, Metabolism and Cardiovascular Diseases. 20: 41-48. PMID 19361966 DOI: 10.1016/J.Numecd.2009.02.006 |
0.433 |
|
| 2010 |
Biagioni F, Bossel N, Fontemaggi G, Antoniani B, Benedetto AD, Strano S, Muti P, Mottolese M, Domany E, Blandino G. Abstract 3010: The advent of miRNAs in the molecular taxonomy of breast cancer Cellular and Molecular Biology. 70: 3010-3010. DOI: 10.1158/1538-7445.Am10-3010 |
0.36 |
|
| 2009 |
Barba M, Yang L, Schünemann HJ, Sperati F, Grioni S, Stranges S, Westerlind KC, Blandino G, Gallucci M, Lauria R, Malorni L, Muti P. Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis. Journal of Experimental & Clinical Cancer Research : Cr. 28: 135. PMID 19814782 DOI: 10.1186/1756-9966-28-135 |
0.314 |
|
| 2009 |
Barba M, Muti P. Is it time to test metformin in breast cancer prevention trials? A reply to the authors. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 2565; author reply 2. PMID 19745224 DOI: 10.1158/1055-9965.Epi-09-0515 |
0.372 |
|
| 2009 |
Muti P, Berrino F, Krogh V, Villarini A, Barba M, Strano S, Blandino G. Metformin, diet and breast cancer: an avenue for chemoprevention. Cell Cycle (Georgetown, Tex.). 8: 2661. PMID 19571669 DOI: 10.4161/Cc.8.16.9226 |
0.408 |
|
| 2009 |
Barba M, Schünemann HJ, Sperati F, Akl EA, Musicco F, Guyatt G, Muti P. The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta-analysis. Clinical Endocrinology. 70: 661-70. PMID 19178532 DOI: 10.1111/J.1365-2265.2008.03459.X |
0.305 |
|
| 2009 |
Sieri S, Krogh V, Bolelli G, Abagnato CA, Grioni S, Pala V, Evangelista A, Allemani C, Micheli A, Tagliabue G, Schunemann HJ, Menard S, Berrino F, Muti P. Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 169-76. PMID 19124495 DOI: 10.1158/1055-9965.Epi-08-0808 |
0.477 |
|
| 2009 |
Yang L, Gaikwad NW, Meza J, Cavalieri EL, Muti P, Trock B, Rogan EG. Novel biomarkers for risk of prostate cancer: results from a case-control study. The Prostate. 69: 41-8. PMID 18816637 DOI: 10.1002/Pros.20850 |
0.341 |
|
| 2009 |
Micheli A, Sanz N, Mwangi-Powell F, Coleman MP, Neal C, Ullrich A, Travado L, Santini LA, Grassi L, Lorenzo FD, Costa A, Dangou JM, Bisanti L, Costantini AS, Abu-Rmeileh N, ... ... Muti P, et al. International collaborations in cancer control and the Third International Cancer Control Congress. Tumori. 95: 579-596. DOI: 10.1177/030089160909500502 |
0.35 |
|
| 2008 |
Crespo CJ, Garcia-Palmieri MR, Smit E, Lee IM, McGee D, Muti P, Figueroa Valle NR, Ramierez-Marrero FA, Freudenheim JL, Sorlie P. Physical activity and prostate cancer mortality in Puerto Rican men. Journal of Physical Activity & Health. 5: 918-29. PMID 19164825 DOI: 10.1123/Jpah.5.6.918 |
0.324 |
|
| 2008 |
Akl EA, Terrenato I, Barba M, Sperati F, Muti P, Schünemann HJ. Extended perioperative thromboprophylaxis in patients with cancer. A systematic review. Thrombosis and Haemostasis. 100: 1176-80. PMID 19132245 DOI: 10.1160/Th08-04-0218 |
0.312 |
|
| 2008 |
Akl EA, Rohilla S, Barba M, Sperati F, Terrenato I, Muti P, Bdair F, Schünemann HJ. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer: a systematic review. Cancer. 113: 1685-94. PMID 18720360 DOI: 10.1002/Cncr.23814 |
0.301 |
|
| 2008 |
Akl EA, Barba M, Rohilla S, Terrenato I, Sperati F, Muti P, Schünemann HJ. Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review. Journal of Experimental & Clinical Cancer Research : Cr. 27: 21. PMID 18634550 DOI: 10.1186/1756-9966-27-21 |
0.341 |
|
| 2008 |
Schernhammer ES, Berrino F, Krogh V, Secreto G, Micheli A, Venturelli E, Sieri S, Sempos CT, Cavalleri A, Schünemann HJ, Strano S, Muti P. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. Journal of the National Cancer Institute. 100: 898-905. PMID 18544743 DOI: 10.1093/Jnci/Djn171 |
0.466 |
|
| 2008 |
Quick SK, Shields PG, Nie J, Platek ME, McCann SE, Hutson AD, Trevisan M, Vito D, Modali R, Lehman TA, Seddon M, Edge SB, Marian C, Muti P, Freudenheim JL. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 1082-7. PMID 18483329 DOI: 10.1158/1055-9965.Epi-07-2755 |
0.439 |
|
| 2008 |
Barba M, Terrenato I, Schünemann HJ, Fuhrman B, Sperati F, Teter B, Gallucci M, D'Amato A, Muti P. Indicators of sexual and somatic development and adolescent body size in relation to prostate cancer risk: results from a case-control study. Urology. 72: 183-7. PMID 18280559 DOI: 10.1016/J.Urology.2007.09.065 |
0.755 |
|
| 2008 |
Fuhrman BJ, Teter BE, Barba M, Byrne C, Cavalleri A, Grant BJ, Horvath PJ, Morelli D, Venturelli E, Muti PC. Equol status modifies the association of soy intake and mammographic density in a sample of postmenopausal women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 33-42. PMID 18199709 DOI: 10.1158/1055-9965.Epi-07-0193 |
0.779 |
|
| 2008 |
Gaikwad NW, Yang L, Muti P, Meza JL, Pruthi S, Ingle JN, Rogan EG, Cavalieri EL. The molecular etiology of breast cancer: evidence from biomarkers of risk. International Journal of Cancer. Journal International Du Cancer. 122: 1949-57. PMID 18098283 DOI: 10.1002/Ijc.23329 |
0.458 |
|
| 2008 |
Akl EA, Muti P, Schünemann HJ. Anticoagulation in patients with cancer: an overview of reviews. Polskie Archiwum Medycyny Wewnetrznej-Polish Archives of Internal Medicine. 118: 183-193. DOI: 10.20452/Pamw.356 |
0.323 |
|
| 2007 |
Sieri S, Pala V, Brighenti F, Pellegrini N, Muti P, Micheli A, Evangelista A, Grioni S, Contiero P, Berrino F, Krogh V. Dietary glycemic index, glycemic load, and the risk of breast cancer in an Italian prospective cohort study. The American Journal of Clinical Nutrition. 86: 1160-6. PMID 17921397 DOI: 10.1093/Ajcn/86.4.1160 |
0.419 |
|
| 2007 |
Capurso G, Schünemann HJ, Terrenato I, Moretti A, Koch M, Muti P, Capurso L, Delle Fave G. Meta-analysis: The use of non-steroidal anti-inflammatory drugs and pancreatic cancer risk for different exposure categories Alimentary Pharmacology and Therapeutics. 26: 1089-1099. PMID 17894651 DOI: 10.1111/J.1365-2036.2007.03495.X |
0.328 |
|
| 2007 |
McCann SE, McCann WE, Hong CC, Marshall JR, Edge SB, Trevisan M, Muti P, Freudenheim JL. Dietary patterns related to glycemic index and load and risk of premenopausal and postmenopausal breast cancer in the Western New York Exposure and Breast Cancer Study. The American Journal of Clinical Nutrition. 86: 465-71. PMID 17684220 DOI: 10.1093/Ajcn/86.2.465 |
0.458 |
|
| 2007 |
Nie J, Beyea J, Bonner MR, Han D, Vena JE, Rogerson P, Vito D, Muti P, Trevisan M, Edge SB, Freudenheim JL. Exposure to traffic emissions throughout life and risk of breast cancer: the Western New York Exposures and Breast Cancer (WEB) study. Cancer Causes & Control : Ccc. 18: 947-55. PMID 17632764 DOI: 10.1007/S10552-007-9036-2 |
0.449 |
|
| 2007 |
Sant M, Allemani C, Sieri S, Krogh V, Menard S, Tagliabue E, Nardini E, Micheli A, Crosignani P, Muti P, Berrino F. Salad vegetables dietary pattern protects against HER-2-positive breast cancer: a prospective Italian study. International Journal of Cancer. 121: 911-4. PMID 17455245 DOI: 10.1002/Ijc.22714 |
0.458 |
|
| 2007 |
Micheli A, Secreto G, Meneghini E, Krogh V, Muti P, Venturelli E, Berrino F. Re: Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. Journal of the National Cancer Institute. 99: 408-9; author reply . PMID 17341734 DOI: 10.1093/Jnci/Djk079 |
0.453 |
|
| 2007 |
McCann SE, Wactawski-Wende J, Kufel K, Olson J, Ovando B, Kadlubar SN, Davis W, Carter L, Muti P, Shields PG, Freudenheim JL. Changes in 2-hydroxyestrone and 16alpha-hydroxyestrone metabolism with flaxseed consumption: modification by COMT and CYP1B1 genotype. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 256-62. PMID 17301257 DOI: 10.1158/1055-9965.Epi-06-0633 |
0.311 |
|
| 2007 |
Akl EA, Barba M, Muti P, Rohilla S, Schünemann H, Sperati F, Terrenato I. Anticoagulation for the intial treatment of venous thromboembolism in patients with cancer Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.Cd006649 |
0.316 |
|
| 2006 |
Barba M, Cavalleri A, Schunemann HJ, Krogh V, Evangelista A, Secreto G, Micheli A, Zhou Q, Fuhrman B, Teter B, Berrino F, Muti P. Reliability of urinary 6-sulfatoxymelatonin as a biomarker in breast cancer. The International Journal of Biological Markers. 21: 242-245. PMID 28207149 DOI: 10.5301/Jbm.2008.345 |
0.756 |
|
| 2006 |
Muti P, Rogan E, Cavalieri E. Androgens and estrogens in the etiology and prevention of breast cancer. Nutrition and Cancer. 56: 247-52. PMID 17474872 DOI: 10.1207/S15327914Nc5602_17 |
0.46 |
|
| 2006 |
Han D, Nie J, Bonner MR, McCann SE, Muti P, Trevisan M, Ramirez-Marrero FA, Vito D, Freudenheim JL. Lifetime adult weight gain, central adiposity, and the risk of pre- and postmenopausal breast cancer in the Western New York exposures and breast cancer study. International Journal of Cancer. Journal International Du Cancer. 119: 2931-7. PMID 17016824 DOI: 10.1002/Ijc.22236 |
0.434 |
|
| 2006 |
Zeleniuch-Jacquotte A, Lundin E, Micheli A, Koenig KL, Lenner P, Muti P, Shore RE, Johansson I, Krogh V, Lukanova A, Stattin P, Afanasyeva Y, Rinaldi S, Arslan AA, Kaaks R, et al. Circulating enterolactone and risk of endometrial cancer. International Journal of Cancer. Journal International Du Cancer. 119: 2376-81. PMID 16929490 DOI: 10.1002/Ijc.22140 |
0.43 |
|
| 2006 |
Cavalieri E, Chakravarti D, Guttenplan J, Hart E, Ingle J, Jankowiak R, Muti P, Rogan E, Russo J, Santen R, Sutter T. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochimica Et Biophysica Acta. 1766: 63-78. PMID 16675129 DOI: 10.1016/J.Bbcan.2006.03.001 |
0.397 |
|
| 2006 |
Barba M, McCann SE, Nie J, Vito D, Stranges S, Fuhrman B, Trevisan M, Muti P, Freudenheim JL. Perinatal exposures and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study. Cancer Causes & Control : Ccc. 17: 395-401. PMID 16596291 DOI: 10.1007/S10552-005-0481-5 |
0.725 |
|
| 2006 |
McCann SE, Kulkarni S, Trevisan M, Vito D, Nie J, Edge SB, Muti P, Freudenheim JL. Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status. Breast Cancer Research and Treatment. 99: 309-11. PMID 16541305 DOI: 10.1007/S10549-006-9196-X |
0.457 |
|
| 2006 |
Fuhrman BJ, Barba M, Krogh V, Micheli A, Pala V, Lauria R, Chajes V, Riboli E, Sieri S, Berrino F, Muti P. Erythrocyte membrane phospholipid composition as a biomarker of dietary fat. Annals of Nutrition & Metabolism. 50: 95-102. PMID 16373991 DOI: 10.1159/000090496 |
0.634 |
|
| 2006 |
Teter B, Fuhrman B, Barba M, Muti P. Melatonin and Mammographic Breast Density American Journal of Epidemiology. 163: S101-S101. DOI: 10.1093/Aje/163.Suppl_11.S101-D |
0.761 |
|
| 2005 |
Rinaldi S, Toniolo P, Muti P, Lundin E, Zeleniuch-Jacquotte A, Arslan A, Micheli A, Lenner P, Dossus L, Krogh V, Shore RE, Koenig KL, Riboli E, Stattin P, Berrino F, et al. IGF-I, IGFBP-3 and breast cancer in young women: a pooled re-analysis of three prospective studies. European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (Ecp). 14: 493-6. PMID 16284492 DOI: 10.1097/00008469-200512000-00001 |
0.448 |
|
| 2005 |
Bonner MR, Nie J, Han D, Vena JE, Rogerson P, Muti P, Trevisan M, Edge SB, Freudenheim JL. Secondhand smoke exposure in early life and the risk of breast cancer among never smokers (United States). Cancer Causes & Control : Ccc. 16: 683-9. PMID 16049807 DOI: 10.1007/S10552-005-1906-X |
0.428 |
|
| 2005 |
Han D, Rogerson PA, Bonner MR, Nie J, Vena JE, Muti P, Trevisan M, Freudenheim JL. Assessing spatio-temporal variability of risk surfaces using residential history data in a case control study of breast cancer. International Journal of Health Geographics. 4: 9. PMID 15826315 DOI: 10.1186/1476-072X-4-9 |
0.408 |
|
| 2005 |
Platek M, Krogh V, Micheli A, Browne R, Meneghini E, Sieri S, Schünemann HJ, Pala V, Barba M, Wilding GE, Berrino F, Muti P. Serum fructosamine and subsequent breast cancer risk: A nested case-control study in the ORDET prospective cohort study Cancer Epidemiology Biomarkers and Prevention. 14: 271-274. PMID 15668507 |
0.381 |
|
| 2005 |
Bonner MR, Han D, Nie J, Rogerson P, Vena JE, Muti P, Trevisan M, Edge SB, Freudenheim JL. Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 53-60. PMID 15668476 |
0.316 |
|
| 2005 |
Fuhrman B, Barba M, Schünemann HJ, Hurd T, Quattrin T, Cartagena R, Carruba G, Muti P. Basal growth hormone concentrations in blood and the risk for prostate cancer: A case-control study Prostate. 64: 109-115. PMID 15666390 DOI: 10.1002/Pros.20203 |
0.69 |
|
| 2005 |
Muti P. The role of endogenous hormones in the etiology and prevention of breast cancer: the epidemiological evidence. Annals of the New York Academy of Sciences. 1028: 273-82. PMID 15650252 DOI: 10.1196/annals.1322.031 |
0.338 |
|
| 2005 |
Muti P. The role of endogenous hormones in the etiology and prevention of breast cancer: the epidemiological evidence Recent Results in Cancer Research. Fortschritte Der Krebsforschung. ProgrèS Dans Les Recherches Sur Le Cancer. 166: 245-256. PMID 15648194 DOI: 10.1007/3-540-26980-0_16 |
0.449 |
|
| 2005 |
Berrino F, Pasanisi P, Bellati C, Venturelli E, Krogh V, Mastroianni A, Berselli E, Muti P, Secreto G. Serum testosterone levels and breast cancer recurrence International Journal of Cancer. 113: 499-502. PMID 15455345 DOI: 10.1002/Ijc.20582 |
0.458 |
|
| 2005 |
Quick SK, Nie J, Ambrosone CB, Shields PG, Muti P, Smit E, Hutson AD, Trevisan M, Freudenheim JL. 085-S: Effect Modification by Catalase Genotype Suggests a Role for Oxidative Stress in the Relationship Between Hormone Replacement Therapy (HRT) Use and Breast Cancer Risk American Journal of Epidemiology. 161. DOI: 10.1093/Aje/161.Supplement_1.S22 |
0.388 |
|
| 2004 |
Barba M, McCann SE, Schünemann HJ, Stranges S, Fuhrman B, De Placido S, Carruba G, Freudenheim JL, Trevisan M, Russell M, Nochajski T, Muti P. Lifetime total and beverage specific--alcohol intake and prostate cancer risk: a case-control study. Nutrition Journal. 3: 23. PMID 15588306 DOI: 10.1186/1475-2891-3-23 |
0.675 |
|
| 2004 |
Han D, Rogerson PA, Nie J, Bonner MR, Vena JE, Vito D, Muti P, Trevisan M, Edge SB, Freudenheim JL. Geographic clustering of residence in early life and subsequent risk of breast cancer (United States). Cancer Causes & Control : Ccc. 15: 921-9. PMID 15577294 DOI: 10.1007/S10552-004-1675-Y |
0.39 |
|
| 2004 |
Micheli A, Muti P, Secreto G, Krogh V, Meneghini E, Venturelli E, Sieri S, Pala V, Berrino F. Endogenous sex hormones and subsequent breast cancer in premenopausal women International Journal of Cancer. 112: 312-318. PMID 15352045 DOI: 10.1002/Ijc.20403 |
0.442 |
|
| 2004 |
McCann SE, Ip C, Ip MM, McGuire MK, Muti P, Edge SB, Trevisan M, Freudenheim JL. Dietary intake of conjugated linoleic acids and risk of premenopausal and postmenopausal breast cancer, Western New York Exposures and Breast Cancer Study (WEB Study). Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 1480-4. PMID 15342449 |
0.375 |
|
| 2004 |
McCann SE, Muti P, Vito D, Edge SB, Trevisan M, Freudenheim JL. Dietary lignan intakes and risk of pre- and postmenopausal breast cancer. International Journal of Cancer. Journal International Du Cancer. 111: 440-3. PMID 15221974 DOI: 10.1002/Ijc.20262 |
0.479 |
|
| 2004 |
Sieri S, Krogh V, Pala V, Muti P, Micheli A, Evangelista A, Tagliabue G, Berrino F. Dietary patterns and risk of breast cancer in the ORDET cohort Cancer Epidemiology Biomarkers and Prevention. 13: 567-572. PMID 15066921 |
0.359 |
|
| 2004 |
Wu T, Sempos CT, Freudenheim JL, Muti P, Smit E. Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults. Annals of Epidemiology. 14: 195-201. PMID 15036223 DOI: 10.1016/S1047-2797(03)00119-4 |
0.341 |
|
| 2004 |
Lukanova A, Lundin E, Zeleniuch-Jacquotte A, Muti P, Mure A, Rinaldi S, Dossus L, Micheli A, Arslan A, Lenner P, Shore RE, Krogh V, Koenig KL, Riboli E, Berrino F, et al. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: A cross-sectional study in healthy women European Journal of Endocrinology. 150: 161-171. PMID 14763914 DOI: 10.1530/Eje.0.1500161 |
0.357 |
|
| 2004 |
Lukanova A, Lundin E, Micheli A, Arslan A, Ferrari P, Rinaldi S, Krogh V, Lenner P, Shore RE, Biessy C, Muti P, Riboli E, Koenig KL, Levitz M, Stattin P, et al. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. International Journal of Cancer. Journal International Du Cancer. 108: 425-32. PMID 14648710 DOI: 10.1002/Ijc.11529 |
0.442 |
|
| 2004 |
Lukanova A, Zeleniuch-Jacquotte A, Lundin E, Micheli A, Arslan AA, Rinaldi S, Muti P, Lenner P, Koenig KL, Biessy C, Krogh V, Riboli E, Shore RE, Stattin P, Berrino F, et al. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer. International Journal of Cancer. Journal International Du Cancer. 108: 262-8. PMID 14639613 DOI: 10.1002/Ijc.11544 |
0.401 |
|
| 2003 |
Arslan AA, Zeleniuch-Jacquotte A, Lundin E, Micheli A, Lukanova A, Afanasyeva Y, Lenner P, Krogh V, Muti P, Rinaldi S, Kaaks R, Berrino F, Hallmans G, Toniolo P. Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 12: 1531-5. PMID 14693749 |
0.301 |
|
| 2003 |
Akhmedkhanov A, Lundin E, Guller S, Lukanova A, Micheli A, Ma Y, Afanasyeva Y, Zeleniuch-Jacquotte A, Krogh V, Lenner P, Muti P, Rinaldi S, Kaaks R, Berrino F, Hallmans G, et al. Circulating soluble Fas levels and risk of ovarian cancer. Bmc Cancer. 3: 33. PMID 14690548 DOI: 10.1186/1471-2407-3-33 |
0.371 |
|
| 2003 |
Freudenheim JL, Ram M, Nie J, Muti P, Trevisan M, Shields PG, Bandera EV, Campbell LA, McCann SE, Schunemann HJ, Carosella AM, Vito D, Russell M, Nochajski TH, Goldman R. Lung cancer in humans is not associated with lifetime total alcohol consumption or with genetic variation in alcohol dehydrogenase 3 (ADH3). The Journal of Nutrition. 133: 3619-24. PMID 14608084 DOI: 10.1093/Jn/133.11.3619 |
0.324 |
|
| 2003 |
Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, Stanczyk FZ, Stephenson HE, Falk RT, Miller R, Schatzkin A, Allen DS, Fentiman IS, Key TJ, Wang DY, ... ... Muti P, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. Journal of the National Cancer Institute. 95: 1218-26. PMID 12928347 DOI: 10.1093/Jnci/Djg022 |
0.445 |
|
| 2003 |
Dorn JM, Hovey K, Muti P, Freudenheim JL, Russell M, Nochajski TH, Trevisan M. Alcohol drinking patterns differentially affect central adiposity as measured by abdominal height in women and men. The Journal of Nutrition. 133: 2655-62. PMID 12888654 DOI: 10.1093/Jn/133.8.2655 |
0.307 |
|
| 2003 |
Lukanova A, Lundin E, Micheli A, Akhmedkhanov A, Rinaldi S, Muti P, Lenner P, Biessy C, Krogh V, Riboli E, Hallmans G, Berrino F, Zeleniuch-Jacquotte A, Toniolo P, Kaaks R. Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulin-like growth factor binding proteins-1 and -2 (USA, Sweden, Italy). Cancer Causes & Control : Ccc. 14: 285-92. PMID 12814208 DOI: 10.1023/A:1023688603547 |
0.304 |
|
| 2003 |
Bandera EV, Kushi LH, Olson SH, Chen WY, Muti P. Alcohol consumption and endometrial cancer: Some unresolved issues Nutrition and Cancer. 45: 24-29. PMID 12791501 DOI: 10.1207/S15327914Nc4501_3 |
0.355 |
|
| 2003 |
Hurd TC, Muti P, Erwin DO, Womack S. An evaluation of the integration of non-traditional learning tools into a community based breast and cervical cancer education program: The witness project of Buffalo Bmc Cancer. 3. PMID 12775219 DOI: 10.1186/1471-2407-3-18 |
0.302 |
|
| 2003 |
McCann SE, Sempos C, Freudenheim JL, Muti P, Russell M, Nochajski TH, Ram M, Hovey K, Trevisan M. Alcoholic beverage preference and characteristics of drinkers and nondrinkers in western New York (United States) Nutrition, Metabolism and Cardiovascular Diseases. 13: 2-11. PMID 12772432 DOI: 10.1016/S0939-4753(03)80162-X |
0.318 |
|
| 2003 |
Lukanova A, Lundin E, Akhmedkhanov A, Micheli A, Rinaldi S, Zeleniuch-Jacquotte A, Lenner P, Muti P, Biessy C, Krogh V, Berrino F, Hallmans G, Riboli E, Kaaks R, Toniolo P. Circulating levels of sex steroid hormones and risk of ovarian cancer. International Journal of Cancer. Journal International Du Cancer. 104: 636-42. PMID 12594820 DOI: 10.1002/Ijc.10990 |
0.416 |
|
| 2002 |
Muti P, Westerlind K, Wu T, Grimaldi T, De Berry J, Schünemann H, Freudenheim JL, Hill H, Carruba G, Bradlow L. Urinary estrogen metabolites and prostate cancer: a case-control study in the United States. Cancer Causes & Control : Ccc. 13: 947-55. PMID 12588091 DOI: 10.1023/A:1021986811425 |
0.359 |
|
| 2002 |
Muti P, Quattrin T, Grant BJ, Krogh V, Micheli A, Schünemann HJ, Ram M, Freudenheim JL, Sieri S, Trevisan M, Berrino F. Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 11: 1361-8. PMID 12433712 |
0.341 |
|
| 2002 |
Morimoto LM, White E, Chen Z, Chlebowski RT, Hays J, Kuller L, Lopez AM, Manson J, Margolis KL, Muti PC, Stefanick ML, McTiernan A. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes & Control : Ccc. 13: 741-51. PMID 12420953 DOI: 10.1023/A:1020239211145 |
0.371 |
|
| 2002 |
Lukanova A, Lundin E, Toniolo P, Micheli A, Akhmedkhanov A, Rinaldi S, Muti P, Lenner P, Biessy C, Krogh V, Zeleniuch-Jacquotte A, Berrino F, Hallmans G, Riboli E, Kaaks R. Circulating levels of insulin-like growth factor-I and risk of ovarian cancer International Journal of Cancer. 101: 549-554. PMID 12237896 DOI: 10.1002/Ijc.10613 |
0.41 |
|
| 2002 |
Sieri S, Krogh V, Muti P, Micheli A, Pala V, Crosignani P, Berrino F. Fat and protein intake and subsequent breast cancer risk in postmenopausal women Nutrition and Cancer. 42: 10-17. PMID 12235640 DOI: 10.1207/S15327914Nc421_2 |
0.466 |
|
| 2002 |
Lukanova A, Toniolo P, Lundin E, Micheli A, Akhmedkhanov A, Muti P, Zeleniuch-Jacquotte A, Biessy C, Lenner P, Krogh V, Berrino F, Hallmans G, Riboli E, Kaaks R. Body mass index in relation to ovarian cancer: A multi-centre nested case-control study International Journal of Cancer. 99: 603-608. PMID 11992553 DOI: 10.1002/Ijc.10374 |
0.412 |
|
| 2001 |
Swede H, Moysich KB, Freudenheim JL, Quirk JT, Muti PC, Hurd TC, Edge SB, Winston JS, Michalek AM. Breast cancer risk factors and HER2 over-expression in tumors. Cancer Detection and Prevention. 25: 511-9. PMID 12132871 |
0.33 |
|
| 2001 |
Schisterman EF, Faraggi D, Browne R, Freudenheim J, Dorn J, Muti P, Armstrong D, Reiser B, Trevisan M. TBARS and cardiovascular disease in a population-based sample Journal of Cardiovascular Risk. 8: 219-225. PMID 11551000 DOI: 10.1177/174182670100800406 |
0.316 |
|
| 2001 |
Pala V, Krogh V, Muti P, Chajès V, Riboli E, Micheli A, Saadatian M, Sieri S, Berrino F. Erythrocyte membrane fatty acids and subsequent breast cancer: A prospective Italian study Journal of the National Cancer Institute. 93: 1088-1095. PMID 11459870 DOI: 10.1093/Jnci/93.14.1088 |
0.421 |
|
| 2000 |
Muti P, Stanulla M, Micheli A, Krogh V, Freudenheim JL, Yang J, Schünemann HJ, Trevisan M, Berrino F. Markers of insulin resistance and sex steroid hormone activity in relation to breast cancer risk: a prospective analysis of abdominal adiposity, sebum production, and hirsutism (Italy). Cancer Causes & Control : Ccc. 11: 721-30. PMID 11065009 DOI: 10.1023/A:1008966623901 |
0.41 |
|
| 2000 |
Muti P, Bradlow HL, Micheli A, Krogh V, Freudenheim JL, Schünemann HJ, Stanulla M, Yang J, Sepkovic DW, Trevisan M, Berrino F. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology (Cambridge, Mass.). 11: 635-40. PMID 11055622 DOI: 10.1097/00001648-200011000-00004 |
0.479 |
|
| 2000 |
Muti P, Khan SA. Correspondence re: S. A. Khan et al., The normal breast epithelium of women with breast cancer displays an aberrant response to Estradiol. Cancer Epidemiol. Biomark. Prev., 8: 867-872, 1999 [2] (multiple letters) Cancer Epidemiology Biomarkers and Prevention. 9: 535-536. PMID 10815702 |
0.301 |
|
| 1999 |
Freudenheim JL, Ambrosone CB, Moysich KB, Vena JE, Graham S, Marshall JR, Muti P, Laughlin R, Nemoto T, Harty LC, Adam Crits G, Chan AWK, Shields PG. Alcohol dehydrogenase 3 genotype modification of the association of alcohol consumption with breast cancer risk Cancer Causes and Control. 10: 369-377. PMID 10530606 DOI: 10.1023/A:1008950717205 |
0.384 |
|
| 1998 |
Micheli A, Mariotto A, Giorgi Rossi A, Gatta G, Muti P. The prognostic role of gender in survival of adult cancer patients European Journal of Cancer. 34: 2271-2278. PMID 10070298 DOI: 10.1016/S0959-8049(98)00324-4 |
0.394 |
|
| 1998 |
O'Dowd KJ, Freudenheim JL, Vena JE, Muti P. Re: 'Lactation history and breast cancer risk' [2] (multiple letters) American Journal of Epidemiology. 148: 1134. PMID 9850138 |
0.328 |
|
| 1997 |
Freudenheim JL, Marshall JR, Vena JE, Moysich KB, Muti P, Laughlin R, Nemoto T, Graham S. Lactation history and breast cancer risk American Journal of Epidemiology. 146: 932-938. PMID 9400334 DOI: 10.1093/Oxfordjournals.Aje.A009219 |
0.459 |
|
| 1996 |
Muti P, Trevisan M, Panico S, Micheli A, Celentano E, Freudenheim JL, Berrino F. Body fat distribution, peripheral indicators of androgenic activity, and blood pressure in women Annals of Epidemiology. 6: 181-187. PMID 8827152 DOI: 10.1016/1047-2797(96)00008-7 |
0.337 |
|
| 1996 |
Berrino F, Muti P, Micheli A, Bolelli G, Krogh V, Sciajno R, Pisani P, Panico S, Secreto G. Serum sex hormone levels after menopause and subsequent breast cancer Journal of the National Cancer Institute. 88: 291-296. PMID 8614008 DOI: 10.1093/Jnci/88.5.291 |
0.463 |
|
| 1995 |
Freudenheim J, Marshall J, Graham S, Laughlin R, Vena J, Bandera E, Muti P, Swanson M, Nemoto T. Exposure to breastmilk in infancy and the risk of breast cancer Maturitas. 21: 159. DOI: 10.1016/0378-5122(95)90002-0 |
0.308 |
|
| 1994 |
Freudenheim JL, Marshall JR, Graham S, Laughlin R, Vena JE, Bandera E, Muti P, Swanson M, Nemoto T. Exposure to breastmilk in infancy and the risk of breast cancer Epidemiology. 5: 324-331. PMID 8038247 DOI: 10.1016/0378-5122(95)90002-0 |
0.476 |
|
| 1994 |
Freudenheim J, Marshall J, Graham S, Laughlin R, Vena J, Bandera E, Muti P, Swanson M, Nemoto T. 94143439 Exposure to breastmilk in infancy and the risk of breast cancer Maturitas. 20: 224. DOI: 10.1016/0378-5122(94)90031-0 |
0.421 |
|
| 1992 |
Panico S, Dello Iacovo R, Celentano E, Galasso R, Muti P, Salvatore M, Mancini M. Progetto ATENA, A study on the etiology of major chronic diseases in women: Design, rationale and objectives European Journal of Epidemiology. 8: 601-608. PMID 1397231 DOI: 10.1007/Bf00146383 |
0.304 |
|
| 1990 |
Panico S, Pisani P, Muti P, Recchione C, Cavalleri A, Totis A, Berrino F. Diurnal variation of testosterone and estradiol: a source of bias in comparative studies on breast cancer Journal of Endocrinological Investigation: Official Journal of the Italian Society of Endocrinology. 13: 423-426. PMID 2380505 DOI: 10.1007/Bf03350695 |
0.374 |
|
| 1989 |
Berrino F, Muti P. Mediterranean diet and cancer European Journal of Clinical Nutrition. 43: 49-55. PMID 2557204 |
0.311 |
|
| 1988 |
Muti P, Pisani P, Crosignani P, Micheli A, Panico S, Secreto G, Berrino F. ORDET - prospective study on hormones, diet and breast cancer: Feasibility studies and long-term quality control Steroids. 52: 395-396. PMID 3250034 DOI: 10.1016/0039-128X(88)90164-X |
0.387 |
|
| Show low-probability matches. |